EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genomic Evaluation of Canine Prostatic Carcinomas as a Model for the Human Disease: or ‘UC or not UC – that is the question’

Rachael Thomas iD, Jennifer A Luff, Allison N Dickey, Megan N Dillon iD, Isabella G Livingston iD, Carter A Schrag, Steven E Suter iD, Matthew Breen

Veterinary and Comparative Oncology · 2025-12 · 23 (4) · 528-548

DOI: 10.1111/vco.70006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 23.07.2025. Verfasst von Rachael Thomas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Dog Diseases, Prostatic Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Goodnight Scholars Program, NIEHS NIH HHS, North Carolina State University Office of Undergraduate Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spontaneous canine prostate cancer (PC) is widely considered a pertinent clinical model for the human disease. While over 95% of PC in men are adenocarcinomas, arising from prostatic glandular epithelium, it is increasingly recognised that many canine PC are of urothelial origin, arising within the prostatic urethra or ducts, or through invasion from a primary urinary bladder tumour. At diagnosis, canine prostatic tumours are often poorly differentiated and widely disseminated, masking the primary site and limiting the sensitivity of cellular biomarkers. Consequently, published studies of canine PC show varying representation of glandular versus urothelial tumours, yielding conflicting observations regarding their molecular pathogenesis and clinical behaviour. We characterised DNA sequence mutations and copy number aberrations in 31 canine PC, seeking evidence supporting relevance as a disease model. Only three tumours resembled adenocarcinomas. The remainder were either histologically consistent with urothelial carcinoma ( n = 15), showed mixed glandular and urothelial morphology ( n = 4), or were carcinomas of undetermined cell type ( n = 9). BRAF V588E mutation was detected in 87% of tumours, including all three adenocarcinomas. Urinary bladder involvement was evident in 46% of cases, but none of the adenocarcinomas. Genome‐wide DNA copy number instability was apparent throughout the cohort, with chromosome 36 gain significantly associated with urothelial tumours. Hallmark alterations of human PC, such as defects within PI3K and androgen receptor signalling pathways, were not detected. Improved molecular subclassification of canine PC is needed to direct selection of relevant cases for modelling the human disease and to ensure appropriate extrapolation between canine and human studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesProstatic NeoplasmsAdenocarcinomaDogsAnimalsMaleDisease Models, AnimalHumansMutationUrinary Bladder NeoplasmsDNA Copy Number VariationsGenomics

Stichwörter der Autor:innen

DNA copy number variationsadenocarcinomadogsmutationprostatic neoplasmsurologic neoplasms

Autor:innen und Institutionen

  • Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
  • Comparative Medicine Institute, North Carolina State University, Raleigh, North Carolina, USA.
  • Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
  • Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, USA.
  • Center for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina, USA.
  • Department of Biological Sciences, College of Sciences, North Carolina State University, Raleigh, North Carolina, USA.

ORCID-Profile: Rachael Thomas, Megan N Dillon, Isabella G Livingston, Steven E Suter

Förderung

  • Goodnight Scholars Program
  • NIEHS NIH HHS
  • North Carolina State University Office of Undergraduate Research
  • Canine Cancer Genomics Fund, NC State University
  • National Institute of Environmental Health Sciences

Zitieren

APA

Thomas, R., Luff, J. A., Dickey, A. N., Dillon, M. N., Livingston, I. G., Schrag, C. A., Suter, S. E., & Breen, M. (2025). Genomic Evaluation of Canine Prostatic Carcinomas as a Model for the Human Disease: or ‘UC or not UC – that is the question’. Veterinary and Comparative Oncology, 23(4), 528-548. https://doi.org/10.1111/vco.70006

Vancouver

Thomas R, Luff JA, Dickey AN, Dillon MN, Livingston IG, Schrag CA, et al. Genomic Evaluation of Canine Prostatic Carcinomas as a Model for the Human Disease: or ‘UC or not UC – that is the question’. Veterinary and Comparative Oncology. 2025;23(4):528-548. doi:10.1111/vco.70006

BibTeX
@article{Thomas2025,
  author = {Thomas, Rachael and Luff, Jennifer A and Dickey, Allison N and Dillon, Megan N and Livingston, Isabella G and Schrag, Carter A and Suter, Steven E and Breen, Matthew},
  title = {Genomic Evaluation of Canine Prostatic Carcinomas as a Model for the Human Disease: or ‘UC or not UC – that is the question’},
  journal = {Veterinary and Comparative Oncology},
  year = {2025},
  volume = {23},
  number = {4},
  pages = {528--548},
  doi = {10.1111/vco.70006}
}
Kostenlos starten →